The Implantable Artificial Heart Project
ABIOMED, Inc.
News
Press Conferences
News Releases
Frequently Asked Questions (FAQ)
Images and Diagrams
The AbioCor Replacement Heart
Frequently Asked Questions (FAQ)
Images and Diagrams
The Researchers
Laman A. Gray, Jr., M.D.
Robert D. Dowling, M.D.

News Releases

FOR IMMEDIATE RELEASE
November 13, 2001
FOR MORE INFORMATION:
Linda McGinity Jackson,
502-587-4603
Mary Jennings,
502-587-4230
Kathy Keadle,
502-852-7504

LOUISVILLE SURGEONS PLAN UPDATE ON STATUS OF FIRST ABIOCOR PATIENT

(LOUISVILLE) - The University of Louisville surgeons who implanted the world's first totally implantable replacement heart in Bob Tools at Jewish Hospital on July 2 announced today that they will update the public on Mr. Tools' condition on Wednesday, November 14 at 2:00 p.m. EST.

Dr. Laman Gray reported a major setback for Mr. Tools, which "began with the onset of weakness in the right side of his body."

Additional details regarding the patients enrolled in the Jewish Hospital/University of Louisville AbioCor clinical trial will not be available until the news briefing.

Dr. Gray and Dr. Robert Dowling will give a full update on Mr. Tools' current diagnosis and prognosis tomorrow at 2:00 p.m. EST in the Conference Center atop the Rudd Heart and Lung Center on the Jewish Hospital campus.

The news conference will be up-linked live via satellite coordinates Ku-Band SBS 6, Transponder 7, Horizontal Frequency 11872 MHZ, 74 degrees West. The audio frequency is 6.20/6.80. The signal will be available from 2-3 p.m. (EST), Wednesday, November 14.

The news conference will also be web cast at www.heartpioneers.com. For future reference, the press conference will be archived on www.heartpioneers.com.

Printer friendly version (Adobe Acrobat Reader Required)


©2001 Jewish Hospital, University of Louisville Health Sciences Center, ABIOMED, Inc.
Jewish Hospital University of Louisville Health Sciences Center